Scholarlink

Purpose <p>This study aimed to evaluate the knowledge, attitudes, and experiences of glaucoma patients about the side effects of intraocular pressure (IOP)-lowering medications in glaucoma, focusing on how these factors affect treatment adherence.</p> Methods <p>We conducted a cross-sectional survey during routine visits to glaucoma clinic, with participants aged 18&#xa0;years or older on IOP-lowering medications for at least 6&#xa0;months. The survey, consisting of 22 questions about various aspects of IOP-lowering medications and side effects.</p> Results <p>Most out of 398 analysed patients were not informed about side effects when IOP-lowering medication was prescribed, and 68.1% reported experiencing side effects. A significant number of participants reported changing IOP-lowering medications due to side effects. Higher self-reported knowledge about side effects was associated with lower concern (coef. = −&#xa0;0.1636, <i>P</i> = 0.048) about side effects.</p> Conclusion <p>The study identified significant gaps in patient education and support about IOP-lowering medications side effects. Better communication and education by healthcare providers could improve treatment adherence, consequentially enhancing clinical outcomes and quality of life for glaucoma patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

How patients deal with side-effects of topical intraocular pressure-lowering medication in glaucoma: a cross-sectional study from a tertiary ophthalmology clinic

  • 期刊论文

  • 发表日期：

    2025年7月19日

查看全文
  • Ante Krešo,
  • Darko Batistić,
  • Josip Vrdoljak,
  • Ljubo Znaor,
  • Ana Marušić

摘要

Purpose

This study aimed to evaluate the knowledge, attitudes, and experiences of glaucoma patients about the side effects of intraocular pressure (IOP)-lowering medications in glaucoma, focusing on how these factors affect treatment adherence.

Methods

We conducted a cross-sectional survey during routine visits to glaucoma clinic, with participants aged 18 years or older on IOP-lowering medications for at least 6 months. The survey, consisting of 22 questions about various aspects of IOP-lowering medications and side effects.

Results

Most out of 398 analysed patients were not informed about side effects when IOP-lowering medication was prescribed, and 68.1% reported experiencing side effects. A significant number of participants reported changing IOP-lowering medications due to side effects. Higher self-reported knowledge about side effects was associated with lower concern (coef. = − 0.1636, P = 0.048) about side effects.

Conclusion

The study identified significant gaps in patient education and support about IOP-lowering medications side effects. Better communication and education by healthcare providers could improve treatment adherence, consequentially enhancing clinical outcomes and quality of life for glaucoma patients.